Your browser doesn't support javascript.
loading
Hitting the sweet spot: optimal use of corticosteroids for immune checkpoint inhibitor side-effects.
Schmitt, Andreas M; Spain, Lavinia; Larkin, James.
Afiliação
  • Schmitt AM; Department of Medical Oncology, The Royal Marsden Hospital NHS Foundation Trust, London, SW3 6JJ, UK; Department of Clinical Research, University Hospital Basel, University of Basel, Basel, Switzerland.
  • Spain L; Peter MacCallum Cancer Centre, Department of Medical Oncology, Melbourne, VIC, Australia; Eastern Health, Department of Medical Oncology, Melbourne, VIC, Australia; Eastern Health Clinical School, Monash University, Melbourne, VIC, Australia.
  • Larkin J; Department of Medical Oncology, The Royal Marsden Hospital NHS Foundation Trust, London, SW3 6JJ, UK. Electronic address: james.larkin@rmh.nhs.uk.
Lancet Oncol ; 23(9): 1123-1124, 2022 09.
Article em En | MEDLINE | ID: mdl-36055300
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos / Inibidores de Checkpoint Imunológico Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos / Inibidores de Checkpoint Imunológico Idioma: En Ano de publicação: 2022 Tipo de documento: Article